statistiche ricercatore

Continente	#
NA - Nord America	1.552
AS - Asia	624
EU - Europa	394
SA - Sud America	106
OC - Oceania	21
Continente sconosciuto - Info sul continente non disponibili	15
AF - Africa	9
Totale	2.721

Nazione	#
US - Stati Uniti d'America	1.490
SG - Singapore	223
CN - Cina	101
IT - Italia	101
HK - Hong Kong	100
VN - Vietnam	85
BR - Brasile	81
SE - Svezia	63
GB - Regno Unito	60
DE - Germania	34
BD - Bangladesh	33
FI - Finlandia	32
CA - Canada	30
RU - Federazione Russa	22
MX - Messico	20
ES - Italia	18
AU - Australia	14
JP - Giappone	13
FR - Francia	12
IN - India	12
NL - Olanda	12
PL - Polonia	12
AR - Argentina	11
BG - Bulgaria	10
KR - Corea	10
ID - Indonesia	8
CO - Colombia	7
DK - Danimarca	7
NZ - Nuova Zelanda	7
TR - Turchia	7
UZ - Uzbekistan	6
IQ - Iraq	5
CR - Costa Rica	4
ZA - Sudafrica	4
EC - Ecuador	3
JO - Giordania	3
NO - Norvegia	3
PH - Filippine	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
EG - Egitto	2
IL - Israele	2
IR - Iran	2
JM - Giamaica	2
MY - Malesia	2
NI - Nicaragua	2
PK - Pakistan	2
SA - Arabia Saudita	2
UA - Ucraina	2
VE - Venezuela	2
BB - Barbados	1
BY - Bielorussia	1
BZ - Belize	1
CL - Cile	1
DZ - Algeria	1
GH - Ghana	1
IE - Irlanda	1
KW - Kuwait	1
LT - Lituania	1
MA - Marocco	1
MO - Macao, regione amministrativa speciale della Cina	1
PE - Perù	1
SI - Slovenia	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
Totale	2.706

Nome	#
The complex relationship between female age and embryo euploidy	904
The negative impact of most relevant infections on fertility and Assisted Reproduction Technology	260
Progestins for pituitary suppression during ovarian stimulation for ART: A comprehensive and systematic review including meta-analyses	210
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays	205
The predicted probability of live birth in In Vitro Fertilization varies during important stages throughout the treatment: analysis of 114,882 first cycles	200
Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation	199
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?	178
The interchangeability of two assays for the measurement of anti-Müllerian hormone when personalizing the dose of FSH in in-vitro fertilization cycles	166
Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone	158
Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS	152
The use of oral GnRH antagonists to inhibit the LH surge in women undergoing ovarian stimulation for in vitro fertilization	89
Totale	2.721

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	149	0	0	1	4	2	8	17	9	12	12	60	24
2022/2023	160	26	33	27	4	6	11	0	11	16	1	7	18
2023/2024	146	2	8	6	17	23	2	24	25	8	3	1	27
2024/2025	398	8	0	9	21	81	53	25	19	42	46	35	59
2025/2026	873	78	29	72	93	110	52	119	49	90	74	38	69
2026/2027	810	369	294	147	0	0	0	0	0	0	0	0	0
Totale													2.721